Department of Otolaryngology/Head and Neck Surgery, Mayo Clinic School of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
Otol Neurotol. 2013 Feb;34(2):251-8. doi: 10.1097/mao.0b013e31827d0922.
To investigate surgical, anesthetic, and device-related complications as well as auditory and speech-language development outcomes associated with cochlear implantation (CI) in children 12 months of age and younger.
Retrospective chart review.
Tertiary academic referral center.
All children with severe-to-profound sensorineural hearing loss who underwent cochlear implantation at 12 months of age or younger and an audiometric control group implanted between 13 and 24 months of age.
Anesthetic and surgical course; major and minor surgical, anesthetic and device-related complications; postoperative disposition; postoperative auditory receptive and expressive language development.
Twenty-six patients (41 ears) met criteria. The median duration of follow-up was 58 months. No major surgical or anesthetic complications occurred. One patient (4%) experienced device failure, which required revision surgery and implant exchange. Two other patients (8%) had individual electrode anomalies that were treated with map exclusion. At the last recorded follow-up, 73% of patients were performing at or above the level of normal-hearing age-matched peers. Patients that were implanted at 12 months of age or younger reached age-appropriate speech and language skills by 24 months of age compared with 40 months for the older pediatric control group.
The current study demonstrates that CI provides substantial benefit among infant recipients. Furthermore, when performed by an experienced cochlear implant and pediatric anesthesia team, the surgical and anesthetic risks are similar to that expected with both older pediatric and adult patients.
研究与 12 个月及以下儿童人工耳蜗植入(CI)相关的手术、麻醉和器械相关并发症以及听觉和言语语言发育结局。
回顾性病历审查。
三级学术转诊中心。
所有因重度至极重度感音神经性听力损失而在 12 个月或以下接受人工耳蜗植入且在 13 至 24 个月之间植入并进行听力测试的儿童。
麻醉和手术过程;主要和次要手术、麻醉和器械相关并发症;术后处置;术后听觉接受和表达语言发展。
26 名患者(41 只耳朵)符合标准。中位随访时间为 58 个月。无重大手术或麻醉并发症。1 名患者(4%)出现器械故障,需要进行翻修手术和植入物更换。另外 2 名患者(8%)出现单个电极异常,通过地图排除进行了治疗。在上次记录的随访中,73%的患者表现出与正常听力年龄匹配的同龄人的听力和语言技能相当的水平。在 12 个月或以下植入的患者在 24 个月时达到了适当的言语和语言技能,而年龄较大的儿科对照组则需要 40 个月。
目前的研究表明,CI 为婴儿受者提供了显著的益处。此外,当由经验丰富的人工耳蜗植入和儿科麻醉团队进行时,手术和麻醉风险与年龄较大的儿科和成年患者相似。